Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Eastnine | EAST | Nov 13, 2024 | 45.23 | -0.36 |
EasyFill B | EASYB | Nov 13, 2024 | 0.20 | +18.90 |
EatGood | EATG | Nov 13, 2024 | 0.48 | +5.43 |
eBlitz Group | EBLITZ | Nov 13, 2024 | 1.14 | +3.64 |
Ecoclime Group B | ECCB | Nov 13, 2024 | 2.00 | +8.70 |
ECOMB | ECOM | Nov 13, 2024 | 0.11 | -7.11 |
EcoRub B | ECOB | Nov 13, 2024 | 0.12 | 0.00 |
Edyoutec AB | EDYOU | Nov 13, 2024 | 1.04 | +0.19 |
eEducation Albert | ALBERT | Nov 13, 2024 | 3.70 | -3.90 |
Eevia Health | EEVIA | Nov 13, 2024 | 0.17 | +3.07 |
Effnetplattformen Holding | EFFH | Nov 13, 2024 | 4.06 | +2.53 |
Egetis Therapeutics | EGTX | Nov 13, 2024 | 5.18 | -4.07 |
Elanders B | ELANB | Nov 13, 2024 | 93.80 | -0.53 |
Electrolux A | ELUXA | Nov 13, 2024 | 103.00 | -2.83 |
Electrolux B | ELUXB | Nov 13, 2024 | 86.16 | -2.58 |
Electrolux Professional B | EPROB | Nov 13, 2024 | 69.50 | -1.42 |
Elekta B | EKTAB | Nov 13, 2024 | 63.50 | -1.93 |
Elicera Therapeutics | ELIC | Nov 13, 2024 | 1.97 | -0.25 |
Ellen | ELN | Nov 13, 2024 | 1.08 | +0.93 |
Ellwee | ELLWEE | Nov 13, 2024 | 4.02 | +0.25 |
Elmera Group | ELMRAO | Nov 13, 2024 | 37.65 | 0.00 |
Elon AB (publ) | ELON | Nov 13, 2024 | 25.50 | -3.41 |
Eltel | ELTEL | Nov 13, 2024 | 6.68 | 0.00 |
Embark Group | EMB | Nov 13, 2024 | 0.45 | 0.00 |
EmbeddedArt Group AB (publ) | EMART | Nov 13, 2024 | 6.99 | +4.33 |
Embellence Group | EMBELL | Nov 13, 2024 | 30.30 | +0.33 |
Embracer Group B | EMBRACB | Nov 13, 2024 | 27.10 | +1.04 |
Emilshus | EMILPREF | Nov 13, 2024 | 30.80 | -0.32 |
Emilshus B | EMILB | Nov 13, 2024 | 44.00 | -2.22 |
Enad Global 7 | EG7 | Nov 13, 2024 | 13.40 | -0.59 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.